Toward functional precision oncology to predict, prevent, and treat early metastatic recurrence of triple-negative breast cancer

The University of Utah will receive $6,079,790 under a four-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2022 to June 2026 to develop functional precision oncology approaches to predict, prevent, and treat early metastatic recurrence of triple-negative breast cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions. This award will investigate medical solutions for the battlefield and investigate precision oncology strategies to combat triple-negative breast cancer recurrence, a goal which aligns with the program's focus on impactful medical research. All work will be conducted at the University's facilities in Salt Lake City, Utah.